Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.008 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |